Ahead of the release of their book, “Off Our Chests”, Dr. John Marshall and his wife, Liza, look back on the trials and tribulations of Liza’s triple-negative breast cancer diagnosis – from the perspective of a patient and her husband, the caregiver and oncologist.
Patents with HER2-positive breast cancer had a similar rate of overall survival with Perjeta plus chemotherapy and trastuzumab compared with placebo plus chemotherapy and trastuzumab, although longer follow-up is needed to determine whether a benefit exists in that area.
A cancer survivor pens an ode to her port that has made her journey much less stressful.
A patient with cancer recalls how the love her care team showed her during her treatment made such a difference in her journey to recovery. Her hope: That more patients with cancer around the world can find doctors who treat them as a person, and not just a case.
Moment by moment, we move toward life. We feel what needs to be felt. We can even feel through the numb parts—the broken pieces. Instead of looking somewhere else, we look straight on— at ourselves and others. We see what’s really there. Who is there for us? Who is not? We choose to be with those we love, and those who love us back—like the person in the mirror, the new friend.
Results of a trial assessing endoxifen in patients with breast cancer in Australia were positive enough for the manufacturer to stop the trial before it was scheduled to be completed. The drug’s manufacturer will now accelerate its development in the U.S.
An interim analysis of the PALLAS study showed that adding Ibrance to endocrine therapy, compared to endocrine therapy alone, after initial treatment ended for patients with HR-positive, HER2-negative, early-stage breast cancer did not extend the length of time before a patient’s disease recurred.
Runners will lace up “Everywhere, Together” to Finish Breast Cancer
In this episode of the “CURE Talks Cancer” podcast, we spoke with a patient who is receiving treatment for grade 3 triple-negative breast cancer. We talk about how a nurse’s question during a routine physical “saved her life”, and a kindness challenge she started to help lift her up during the dark days of treatment.
Regular aspirin use may increase survival in patients with bladder and breast cancer.
As a cancer survivor, I’ve found many reasons to celebrate. Here’s one more.
Janice and Rex Cowden sat down for an interview to discuss how to navigate a cancer diagnosis as a couple, and that communication is not only the key to a better cancer journey but a better marriage.
A cancer survivor discusses how she decides to discuss her mastectomy and the acceptance of her body after treatment for cancer.
It's easy to get lost in the statistics of survivorship, but it's important for newly diagnosed patients with cancer to remember that they are not a statistic.
In an interview with CURE®, lead study investigator of the Keynote 355 trial, Dr. Hope S Rugo, discusses the results of the study that led to the FDA approval of the combination therapy and what further data means for certain patients with metastatic triple-negative breast cancer.
The FDA’s fast track designation for ARX788 to treat patients with advanced or metastatic HER2-positive breast cancer who have received at least one previous anti-HER2-based treatment in the metastatic setting, may open the doors to an accelerated approval.
After being diagnosed with the BARD1 gene and undergoing a preventative double mastectomy, Nina Garcia shares her story to raise awareness and offer hope for other women.
In a recent trial, the addition of chemotherapy to endocrine therapy showed clinical benefit in premenopausal women with lymph node-positive, HR-positive, HER2-negative breast cancer.
Choosing to forego breast reconstruction after breast cancer surgery can cause one to feel like the lone ranger, but that feeling doesn’t last long, especially upon the discovery of an entire flattie tribe.
Here's how 3 clinical trials have shaped the overall landscape for patients with HER2 positive breast cancer.
A roundup of some of the most read news and updates in breast cancer in 2020 from CURE®.
Both younger and older women being treated for early breast cancer with chemotherapy are experiencing the same levels of symptom severity and find it a great concern as it interferes with their daily activities.
Highlighting a positive prognosis and improving education in treatment risk could result in lowering the overtreatment of older women who develop early-stage, hormone receptor-positive breast cancer.
How an app supported by Alexa has helped me answer cancer questions.
Catherine Stier, a breast cancer survivor, discusses her new book "When A Kid Like Me Has Cancer" a story of how to talk about cancer with children.
